AdipoPharma

AdipoPharma is a biotechnology company dedicated to understanding the role of adipocytes in diabetes and treating insulin resistance, type 2 diabetes, and related diseases through their unique function in lipid biosynthesis and systemic lipid homeostasis management. The company was founded to commercialize the research achievements of its founder, Dr. Vincent Marion, a biochemist and researcher at INSERM, the French National Institute of Health and Medical Research.